IM Cannabis Reports Second Quarter Financial Results

Go back to IM Cannabis Reports Second Quarter Financial Results

Roth/MKM Reiterates Buy Rating on IM Cannabis Corp. (IMCC)

August 15, 2024 7:20 AM EDT

Roth/MKM analyst Scott Fortune reiterated a Buy rating and $6.00 price target on IM Cannabis Corp. (NASDAQ: IMCC).

The analyst comments "IM Cannabis reported 2Q24 revenue of C$14.8M, an increase of 12% YoY, on the back of a 129% YoY increase in German sales,... More